Literature DB >> 17131464

Identification of endogenous resolvin E1 and other lipid mediators derived from eicosapentaenoic acid via electrospray low-energy tandem mass spectrometry: spectra and fragmentation mechanisms.

Yan Lu1, Song Hong, Rong Yang, Jasim Uddin, Katherine H Gotlinger, Nicos A Petasis, Charles N Serhan.   

Abstract

Resolvin E1 (RvE1, 5S,12R,18R-trihydroxy-6Z,8E,10E,14Z,16E-eicosapentaenoic acid) is a novel anti-inflammatory lipid mediator recently found in humans, mice, and fish in vivo. To identify endogenous RvE1 and other eicosapentaenoic acid (EPA)-derived lipid mediators using electrospray low-energy collision-induced dissociation tandem mass spectrometry (MS/MS), the MS/MS product ion spectra of these compounds were correlated with their structures, and the MS/MS fragmentation mechanisms were studied. Deuterium labeling confirmed the proposed correlations and the fragmentation mechanisms. beta-cleavage was observed for RvE1, and beta and gamma cleavages were seen for leukotriene B5; however, alpha-cleavage was more common. The positions and numbers of hydroxyls and double bonds of these lipid mediators can be deduced from the MS/MS spectra. The MS/MS fragmentation generating chain-cut ions involved beta-ene, gamma-ene, or alpha-H-beta-ene rearrangement, depending on the specific structure. The m/z value of a detected chain-cut ion from RvE1 or from an EPA-derived product is equal to the corresponding hypothetical homolytic segment (cc, cm, mc, or mm) with the addition or extraction of up to two hydrogen atoms (H) from hydroxyls or an alpha-carbon; namely, the m/z value of an alpha-cleavage-generated ion is equal to [cc+H], [cm-2H], [mc-H], or [mm]. Wideband activation increased the signal intensities of chain-cut ions, and therefore was better for trace analysis of RvE1 in biological samples. RvE1, LTB5, PGE3, and other EPA-derived lipid mediators were found in trout brain or head-kidney via this approach on the basis of MS/MS spectra and fragmentation mechanisms. Negative ion electrospray low-collision-energy MS/MS spectra provide adequate data to elucidate and identify the structures of RvE1 and other EPA-derived lipid mediators at levels below a few picomoles in trout samples. Copyright (c) 2006 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17131464     DOI: 10.1002/rcm.2798

Source DB:  PubMed          Journal:  Rapid Commun Mass Spectrom        ISSN: 0951-4198            Impact factor:   2.419


  9 in total

1.  Novel 14S,21-dihydroxy-docosahexaenoic acid rescues wound healing and associated angiogenesis impaired by acute ethanol intoxication/exposure.

Authors:  Haibin Tian; Yan Lu; Shraddha P Shah; Song Hong
Journal:  J Cell Biochem       Date:  2010-10-01       Impact factor: 4.429

Review 2.  Resolvins and protectins in inflammation resolution.

Authors:  Charles N Serhan; Nicos A Petasis
Journal:  Chem Rev       Date:  2011-07-18       Impact factor: 60.622

3.  Metabolomics-lipidomics of eicosanoids and docosanoids generated by phagocytes.

Authors:  Rong Yang; Nan Chiang; Sungwhan F Oh; Charles N Serhan
Journal:  Curr Protoc Immunol       Date:  2011-11

4.  Novel 14,21-dihydroxy-docosahexaenoic acids: structures, formation pathways, and enhancement of wound healing.

Authors:  Yan Lu; Haibin Tian; Song Hong
Journal:  J Lipid Res       Date:  2009-11-05       Impact factor: 5.922

5.  Reduced levels of hydroxylated, polyunsaturated ultra long-chain fatty acids in the serum of colorectal cancer patients: implications for early screening and detection.

Authors:  Shawn A Ritchie; Pearson W K Ahiahonu; Dushmanthi Jayasinghe; Doug Heath; Jun Liu; Yingshen Lu; Wei Jin; Amir Kavianpour; Yasuyo Yamazaki; Amin M Khan; Mohammad Hossain; Khine Khine Su-Myat; Paul L Wood; Kevin Krenitsky; Ichiro Takemasa; Masakazu Miyake; Mitsugu Sekimoto; Morito Monden; Hisahiro Matsubara; Fumio Nomura; Dayan B Goodenowe
Journal:  BMC Med       Date:  2010-02-15       Impact factor: 8.775

6.  Isolevuglandins covalently modify phosphatidylethanolamines in vivo: detection and quantitative analysis of hydroxylactam adducts.

Authors:  Wei Li; James M Laird; Liang Lu; Sanjoy Roychowdhury; Laura E Nagy; Rong Zhou; John W Crabb; Robert G Salomon
Journal:  Free Radic Biol Med       Date:  2009-09-12       Impact factor: 7.376

7.  Reduction of novel circulating long-chain fatty acids in colorectal cancer patients is independent of tumor burden and correlates with age.

Authors:  Shawn A Ritchie; Doug Heath; Yasuyo Yamazaki; Bryan Grimmalt; Amir Kavianpour; Kevin Krenitsky; Hoda Elshoni; Ichiro Takemasa; Masakazu Miyake; Mitsugu Sekimoto; Morito Monden; Takeshi Tomonaga; Hisahiro Matsubara; Kazuyuki Sogawa; Kazuyuki Matsushita; Fumio Nomura; Dayan B Goodenowe
Journal:  BMC Gastroenterol       Date:  2010-11-29       Impact factor: 3.067

Review 8.  E-series resolvin metabolome, biosynthesis and critical role of stereochemistry of specialized pro-resolving mediators (SPMs) in inflammation-resolution: Preparing SPMs for long COVID-19, human clinical trials, and targeted precision nutrition.

Authors:  Charles N Serhan; Stephania Libreros; Robert Nshimiyimana
Journal:  Semin Immunol       Date:  2022-02-16       Impact factor: 11.130

9.  Simultaneous lipidomic analysis of three families of bioactive lipid mediators leukotrienes, resolvins, protectins and related hydroxy-fatty acids by liquid chromatography/electrospray ionisation tandem mass spectrometry.

Authors:  Mojgan Masoodi; Adnan A Mir; Nicos A Petasis; Charles N Serhan; Anna Nicolaou
Journal:  Rapid Commun Mass Spectrom       Date:  2008       Impact factor: 2.419

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.